FEPI:NSD-REX FANG & Innovation Equity Premium Income ETF (USD)

ETF | Others |

Last Closing

USD 55.43

Change

-0.12 (-0.22)%

Market Cap

USD 0.21B

Volume

0.15M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
ACWI iShares MSCI ACWI ETF

+0.10 (+0.09%)

USD 18.71B
IBIT iShares Bitcoin Trust

-2.82 (-7.70%)

USD 17.74B
CGABL The Carlyle Group Inc. 4.625% ..

+0.04 (+0.22%)

USD 16.14B
JEPQ JPMorgan Nasdaq Equity Premium..

-0.18 (-0.33%)

USD 14.61B
TBIL Rbb Fund Inc - Us Treasury 3 M..

N/A

USD 3.07B
IBTE iShares iBonds Dec 2024 Term T..

+0.01 (+0.04%)

USD 2.79B
IBTF iShares iBonds Dec 2025 Term T..

N/A

USD 2.33B
NVDL GraniteShares 2x Long NVDA Dai..

-10.43 (-14.00%)

USD 2.05B
USCL iShares Climate Conscious & Tr..

-0.13 (-0.20%)

USD 2.01B
RILYK B. Riley Financial Inc. 5.50% ..

+0.01 (+0.05%)

USD 1.95B

ETFs Containing FEPI

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.14% 40% F 51% F
Dividend Return 8.42% 98% N/A 99% N/A
Total Return 8.57% 70% C- 70% C-
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.21B 77% C+ 49% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike